Galectin Therapeutics Inc (GALT) insider trading
Every open-market stock purchase and sale by Galectin Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $6.1M over the last 12 months (27 sales).
- Last insider buy: Kary Eldred (Insider), $810, 9 months ago.
Last 12 months: insiders bought $64.6K (6 buys) and sold $6.1M (27 sales). Last close $3.38 on Oct 22, 2026.
Recent GALT insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 31, 2026 | Richard E Uihlein (Insider) | Bought (not open market) | $3,038,537B |
| Jul 31, 2026 | Richard E Uihlein (Insider) | Bought (not open market) | $26,354B |
| Jul 14, 2026 | Khurram Jamil (C-suite exec) | Sold | $83.3K |
| Jul 14, 2026 | Khurram Jamil (C-suite exec) | Bought (not open market) | — |
| Jun 29, 2026 | Khurram Jamil (C-suite exec) | Sold | $239K |
| Jun 29, 2026 | Harold H. Shlevin (Insider) | Sold | $112K |
| Jun 29, 2026 | Khurram Jamil (C-suite exec) | Bought (not open market) | — |
| Jun 29, 2026 | Harold H. Shlevin (Insider) | Bought (not open market) | — |
| Jun 26, 2026 | Harold H. Shlevin (Insider) | Sold | $38.7K |
| Jun 26, 2026 | Khurram Jamil (C-suite exec) | Sold | $12.7K |
| Jun 26, 2026 | Khurram Jamil (C-suite exec) | Sold | $10.2K |
| Jun 26, 2026 | Khurram Jamil (C-suite exec) | Bought (not open market) | — |
| Jun 26, 2026 | Harold H. Shlevin (Insider) | Bought (not open market) | — |
| Jun 26, 2026 | Khurram Jamil (C-suite exec) | Bought (not open market) | — |
| Jun 23, 2026 | Khurram Jamil (C-suite exec) | Sold | $23.7K |
| Jun 23, 2026 | Khurram Jamil (C-suite exec) | Bought (not open market) | — |
| May 26, 2026 | Khurram Jamil (C-suite exec) | Sold | $1.8K |
| May 26, 2026 | Khurram Jamil (C-suite exec) | Bought (not open market) | — |
| Mar 12, 2026 | Henry Brem (Insider) | Bought (not open market) | — |
| Feb 6, 2026 | Kary Eldred (Insider) | Bought | $810 |
| Jan 16, 2026 | Richard E Uihlein (Insider) | Bought (not open market) | $40K |
| Jan 16, 2026 | Joel Lewis (CEO) | Bought (not open market) | — |
| Jan 16, 2026 | Joel Lewis (CEO) | Bought (not open market) | — |
| Jan 16, 2026 | Kary Eldred (Insider) | Bought (not open market) | — |
| Jan 16, 2026 | Elissa J. Schwartz (Insider) | Bought (not open market) | — |
Who's trading GALT
- Richard E Uihlein, Insider: other filings, last Jul 31, 2026
- Khurram Jamil, C-suite exec: sold $1.2M (16 sales), last Jul 14, 2026
- Harold H. Shlevin, Insider: sold $1.1M (11 sales), last Jun 29, 2026
- Henry Brem, Insider: other filings, last Mar 12, 2026
- Kary Eldred, Insider: bought $6K (3 buys), last Feb 6, 2026
- Joel Lewis, CEO: sold $621K (10 sales), last Jan 16, 2026
- Gilbert S Omenn, Insider: other filings, last Jan 16, 2026
- Richard A. Zordani Jr., Insider: other filings, last Jan 16, 2026
- Gilbert F Amelio, Insider: other filings, last Jan 16, 2026
- Jack W Callicutt, CFO: sold $942K (18 sales), last Jan 16, 2026
- Benjamin Carson Sr, Insider: other filings, last Jan 16, 2026
- Kevin D Freeman, Insider: bought $58.5K (3 buys), last Jan 16, 2026
- Elissa J. Schwartz, Insider: other filings, last Jan 16, 2026
- 10X Fund L.P., 10% owner: sold $2.2M (6 sales), last Dec 16, 2025
Get free alerts when an insider at Galectin Therapeutics Inc files a new trade →